Moreover, ADT has been reported to modulate the composition of the immune milieu in the tumour microenvironment by promoting CD8+ T-cell infiltration (Mercader et al., 2001; Gannon et al., 2009; Sorrentino et al., 2011). The gene discussed is CD8A; the disease is neoplasm.